Eversept Partners, LP Merck & Co., Inc. Transaction History

Eversept Partners, LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$83.49 - $94.64 $791,735 - $897,471	-9,483 Closed	0 $0
Q1 2022 Nov 08, 2023	BUY	$73.51 - $82.4 $697,095 - $781,399	9,483 New	9,483 $778,000
Q1 2022 May 16, 2022	SELL	$73.51 - $82.4 $733,115 - $821,775	-9,973 Reduced 51.26%	9,483 $1.99 Million
Q4 2021 Nov 08, 2023	BUY	$72.28 - $90.54 $1.41 Million - $1.76 Million	19,456 New	19,456 $1.49 Million
Q4 2021 Feb 14, 2022	BUY	$72.28 - $90.54 $1.41 Million - $1.76 Million	19,456 New	19,456 $5.03 Million
Q1 2019 May 14, 2019	SELL	$69.58 - $79.36 $3.19 Million - $3.63 Million	-45,800 Closed	0 $0
Q4 2018 Nov 08, 2023	SELL	$65.24 - $75.71 $6.65 Million - $7.72 Million	-102,000 Reduced 69.01%	45,800 $3.34 Million
Q4 2018 Feb 13, 2019	SELL	$65.24 - $75.71 $6.65 Million - $7.72 Million	-102,000 Reduced 69.01%	45,800 $3.53 Million
Q3 2018 Nov 08, 2023	BUY	$57.69 - $67.84 $8.53 Million - $10 Million	147,800 New	147,800 $10 Million
Q3 2018 Nov 14, 2018	BUY	$57.69 - $67.84 $8.53 Million - $10 Million	147,800 New	147,800 $10.6 Million

3,952

1.94B

16M

15M

Ticker MRK
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,533,280,000
Market Cap $227B
Description
Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...

Get notified when there are updates to the investment portfolio of Eversept Partners, LP, based on Form 13F filings with the SEC.

Stay updated on Eversept Partners, LP with notifications on news.